Why Americans Fly to Taiwan for a Full-Body MRI: The Real Cost & Insurance Math

By the time the average American with a PPO plan finishes shopping a full-body MRI in their home market, they've discovered three uncomfortable facts: their insurance considers preventive imaging "not medically necessary," the cash price runs $2,499 at Prenuvo, $1,950 at Ezra, and substantially more at hospital-affiliated radiology centers (all US prices as of 2026-05) — and even with an HSA, only certain expenses qualify for tax-free reimbursement. A growing group of patients is solving the equation differently: they fly to Taiwan, complete the same imaging at a partner like Beitou Health Management Hospital, and pay a fraction of the U.S. cash price.

The U.S. cost gap, in real numbers

Full-body MRI screening occupies a strange middle in American healthcare. It's not preventive care under the Affordable Care Act's USPSTF Grade A or B list, so commercial insurance won't typically cover it. It's not diagnostic — there's no specific symptom — so providers can't bill it under most CPT codes that insurance recognizes (the procedure would map to a combination of CPT 70551 brain MRI without contrast, 71550 chest MRI without contrast, 74181 abdomen MRI without contrast, and 72195/72197 pelvis MRI — billed individually they easily exceed $6,000 at sticker, but insurers reject them as not medically necessary in asymptomatic patients). The result is cash-pay only, and a wide pricing range:

The Taiwan number is not a typo. Our partner hospitals operate at a different cost basis — public-sector subsidies on imaging equipment, lower medical malpractice insurance, and a different physician reimbursement model. The clinical protocol is the same: 3 Tesla MRI scanner (Siemens MAGNETOM Vida or equivalent), board-certified radiologist read, English-language report. For a deeper technical look at the hardware itself, see Taiwan's 3T MRI technology sets the standard in Asia.

What U.S. cash-pay actually buys at each tier

The headline price is only half the conversation. What you're really comparing is scope of care. Here's what each tier delivers — and what it deliberately leaves out.

Prenuvo at $2,499 gets you a full-body MRI sequence (T1, T2, diffusion-weighted) covering 26 organ regions, an annotated report through the Prenuvo app, and a 30-minute virtual debrief with a Prenuvo-affiliated clinician. What it does not include: any blood work, DEXA bone density, coronary calcium scoring, low-dose lung CT, or a coordinated handoff to your primary care physician. If you want a true longitudinal baseline, you'd combine Prenuvo with Function Health ($499/yr) and a separate DEXA appointment ($150–$300 at most U.S. clinics). The stack reaches $3,150–$3,300 before you account for the cardiac and pulmonary imaging that early-stage cancer and atherosclerosis screening typically warrants.

Ezra at $1,950–$2,500 is faster (~22 minutes vs. Prenuvo's hour) thanks to AI-assisted protocols, and the Ezra Plus tier bundles a low-dose chest CT for lung cancer screening — meaningful, because USPSTF Grade B recommends low-dose CT for adults 50–80 with a 20 pack-year smoking history. Still excluded: blood biomarkers, DEXA, abdominal ultrasound. Ezra also operates in fewer cities than Prenuvo, which adds travel for many patients.

Hospital-affiliated radiology (e.g., a major academic medical center's outpatient imaging division) prices each sequence individually. A self-pay full-body MRI is unusual; more often you negotiate brain + chest + abdomen + pelvis as four separate studies, with each radiologist read billed separately. There's no bundled package, no integrated debrief, and the report goes to your ordering physician — who then has to interpret findings outside their specialty. This is the most expensive route by far, and arguably the worst integrated.

New Dawn Health Taiwan packages were designed specifically to bundle what U.S. patients otherwise stitch together: imaging across modalities, blood biomarkers, DEXA, and an in-person physician debrief, all at one location in one morning. The package selection at /services ranges from a focused 4-hour workup to a multi-day executive protocol that adds endoscopy, colonoscopy, and cardiac stress testing.

HSA and FSA: what actually reimburses, and what doesn't

One question we hear constantly from American travelers is whether their Health Savings Account (HSA) or Flexible Spending Account (FSA) will cover a screening trip to Taiwan. The short answer: some of it, with the right paperwork.

• The imaging itself is generally HSA-eligible if you have a Letter of Medical Necessity (LMN) from your U.S. primary care physician. We provide hospital invoices in English with CPT-equivalent procedure codes that your HSA administrator can usually accept.
• The flight, hotel, and ground transportation are not typically HSA-eligible — those are personal travel costs (the IRS allows transportation "primarily for and essential to medical care," but international leisure travel almost always fails this test).
• Pre- and post-screening physician consultation in Taiwan is generally HSA-eligible if billed as a medical service.
• Prescription medications dispensed during the trip (e.g., a follow-up prescription) are generally HSA-eligible if you keep the pharmacy receipt with active ingredient and dose.

For a deeper walkthrough on the paperwork, see our guide on HSA & FSA reimbursement for medical tourism. Note that HSA contribution limits in 2024 are $4,150 (single) and $8,300 (family) — a single Taiwan screening trip including airfare and accommodation typically lands well under the family limit.

How the IRS sees HSA reimbursement of foreign medical care

This is the question that creates the most confusion, because IRS Publication 502 — the controlling document for medical and dental expenses — does not contain the word "international" or "foreign" anywhere in its definition of qualified medical expenses. That silence works in patients' favor more often than people realize.

The operative rule, paraphrased from Pub 502: a qualified medical expense is the cost of "diagnosis, cure, mitigation, treatment, or prevention of disease, or for the purpose of affecting any structure or function of the body," provided by a "legally licensed" practitioner. The publication does not restrict that license to U.S. jurisdictions. In practice, HSA administrators interpret this to mean care provided by a physician licensed in their own country qualifies, provided you can document:

1. The provider's name, credentials, and license jurisdiction (e.g., "Dr. X, MD, licensed by Taiwan Ministry of Health and Welfare")
2. The date and nature of services
3. The amount paid, in USD-equivalent (your credit card statement or a wire transfer record satisfies this)
4. Where applicable, a Letter of Medical Necessity from your U.S. PCP

The Letter of Medical Necessity is the operative document for grey-area expenses like preventive full-body MRI. A defensible LMN includes: patient demographics, the specific medical condition or risk factor being screened (e.g., "family history of early-onset colorectal cancer per ICD-10 Z80.0"), the recommended service with clinical justification, and the prescribing physician's signature, NPI number, and date. We provide a template at intake that most U.S. PCPs are willing to sign after a 15-minute telehealth visit. Keep the LMN with your tax records for at least three years; the IRS retention window for HSA documentation runs as long as the account is open plus three years past the final distribution.

One nuance: HSA reimbursement is self-directed. You don't submit a claim to the IRS at the time of the trip — you simply withdraw HSA funds and retain receipts. The audit risk is real but small (under 1% of HSA-holders are audited on medical expense documentation in any given year), and the documentation above generally satisfies an auditor.

The flight isn't the obstacle it sounds like

EVA Air, China Airlines, and United run multiple daily nonstop flights from LAX, SFO, and SEA to Taipei (TPE), averaging 13–14 hours. From the East Coast, most travelers connect through Tokyo Narita (NRT) or Seoul Incheon (ICN), bringing total travel to 18–20 hours. EVA Air's premium economy on the 787-9 typically runs $1,800–$2,400 round-trip in shoulder seasons (April–May, September–October); business class runs $4,500–$6,800 and includes lie-flat seats that meaningfully reduce jet-lag impact on screening day. Even at premium economy, the round-trip airfare plus 4 hotel nights at a 4-star Taipei property ($150–$220/night) totals $2,500–$3,300 — still less than a single Prenuvo scan in many cases, while the Taiwan package itself is multiples cheaper.

A practical scheduling note: arrive in Taipei at least 36 hours before your screening. Most travelers from the U.S. West Coast benefit from a buffer day to reset circadian rhythm before the 8 AM intake. East Coast travelers should plan a full 48 hours.

Patient persona deep-dive

The "ideal" patient for a Taiwan screening trip isn't one type. Three real personas illustrate the spread:

Persona 1 — The 50-year-old executive doing a baseline. Mark T., 51, financial advisor in Boston. No symptoms, family history of stroke. His U.S. PCP recommended a coronary calcium score and "considering" a Prenuvo, but his HMO wouldn't cover either. Mark booked a 4-day Taipei trip in October, paid $3,099 for the Plus package (full-body MRI + brain MR angiogram + coronary CT angiogram + DEXA + lung CT + ultrasounds), and walked out with a coronary calcium score of 12 (low), a clean MRI, ApoB at 108 mg/dL (above target), and a recommendation to start a low-dose statin. His U.S. cardiologist accepted the report directly.

"I expected to feel like a medical tourist. I felt like a guest. I had a 30-minute physician debrief in English the morning after my MRI, walked out with a bound report I could hand my cardiologist in Boston, and spent the rest of the week in Beitou's hot springs." — Mark T., 51, Boston

Persona 2 — The post-cancer-survivor doing surveillance. Linda R., 47, two years out from Stage I breast cancer treatment, MD Anderson. Her oncologist wanted annual full-body imaging surveillance but the U.S. cash price was prohibitive on top of her existing follow-up costs. Linda's HSA had $11,000 accumulated over four high-deductible plan years. She used $1,499 for the New Dawn package and $980 for premium economy from Houston via Tokyo, both reimbursed from the HSA with a one-page LMN from her oncologist citing ICD-10 Z85.3 (personal history of breast cancer). The Taiwan radiologist's report flagged a 4mm liver lesion as "indeterminate, recommend 6-month follow-up MRI." She'll repeat next May.

Persona 3 — The family with hereditary risk. The Chen family, ages 38 and 42, both BRCA2-positive following a sister's diagnosis. They booked a combined trip with their two teenage children (who did age-appropriate screening only — no MRI for asymptomatic minors). Total package cost for two adults: $2,798. They extended the trip 8 days for a family vacation in Hualien and Taroko Gorge, treating the screening as the anchor of an annual ritual.

Booking from the U.S. — the practical timeline

1. 4–6 weeks out: free 15-minute consult to confirm fit and select a package on /services. The pre-screen consultation covers: prior imaging (if any), current medications, family history (specifically first-degree relatives with cancer or cardiovascular disease before age 60), known contraindications, and HSA/LMN paperwork timing.
2. 3–4 weeks out: $100 fully-refundable deposit secures your morning at a partner hospital. Your U.S. PCP issues the LMN if you're planning HSA reimbursement.
3. 2 weeks out: pre-screen instructions delivered (fasting protocol, what to wear, pre-existing imaging upload). Stop iron supplements and avoid contrast-enhancing skincare 7 days prior.
4. Day before: arrive in Taipei (ideally 36–48 hours pre-screening for jet-lag buffer), light dinner, fast 8 hours.
5. Screening morning: 8 AM intake, 12 PM finish, lunch on us. Bring your passport (required for hospital admission), prior imaging on disc or USB if available, a written list of medications and supplements with dosages, and any insurance/HSA paperwork you want stamped.
6. Following morning: 30-minute physician debrief in English, with the radiologist's preliminary impression already in hand.
7. Within 7 days: full digital report (PDF + DICOM), portable to your U.S. physician.

Contraindications to flag at intake: an active pacemaker or implanted cardiac defibrillator (most modern devices are MR-conditional, but the manufacturer card is required), cochlear implants, certain aneurysm clips placed before 1995, recent surgical clips or stents (within 6 weeks), pregnancy, severe renal impairment if contrast is planned, and severe claustrophobia. Claustrophobia is manageable: our partner hospitals offer wide-bore 3T scanners and oral lorazepam pre-medication on physician approval — book that conversation 2 weeks ahead.

What the radiology report actually contains

A common worry from U.S. patients is whether a Taiwan radiology report will actually be useful to their home physicians. The answer hinges on report structure and DICOM portability — both are taken seriously at our partner hospitals.

A typical New Dawn partner report runs 8–14 pages in English and follows international radiology reporting conventions:

1. Patient demographics and study identifiers — name, DOB, accession number, date and time, ordering clinician.
2. Clinical history and indication — typically "asymptomatic adult, preventive full-body MRI screening; family history per intake."
3. Comparison — references to any prior imaging you provided. This is critical for longitudinal interpretation; a 6mm liver lesion stable over 3 years means something very different from a new 6mm lesion.
4. Technique — scanner make/model (e.g., Siemens MAGNETOM Vida 3T), sequences acquired (T1, T2, DWI, ADC, T2 FLAIR), contrast administration if any, slice thickness.
5. Findings — organ-by-organ in standardized order: brain and ventricles, head/neck soft tissues, thyroid, lungs (when chest CT included), heart and great vessels, liver, gallbladder and biliary tree, pancreas, spleen, adrenals, kidneys, retroperitoneum, GI tract, pelvic organs, bones, soft tissues. Each organ gets explicit "no abnormality" or specific descriptive finding.
6. Impression — the radiologist's prioritized summary of findings, typically 3–8 bullet points.
7. Recommendations — explicit follow-up guidance per finding (e.g., "6-month MRI follow-up of left hepatic lobe lesion; correlate with serum AFP").

Compare this to the Prenuvo app summary, which is well-designed for consumer comprehension but is a derivative product — the underlying radiology report is more clinical and is what a U.S. specialist will actually want to read. We deliver both formats.

DICOM matters because images, not just words, drive specialist follow-up. A U.S. oncologist or hepatologist reviewing an "indeterminate liver lesion" will want to view the actual T2 and DWI sequences themselves, not rely on text. New Dawn delivers the full DICOM dataset (typically 1–3 GB) via secure transfer, which loads directly into PACS systems at U.S. hospitals or into free viewers like Horos or RadiAnt for individual review.

Common findings and follow-up paths

Here's a piece of honesty that most cash-pay imaging providers underemphasize: roughly 25–30% of asymptomatic adults will have something flagged on a full-body MRI. This is not because the patient is sick. It's because human bodies are full of small, benign variations that show up on high-resolution imaging — and screening at 3T resolution finds more of them than older scanners did.

The clinical term is incidentaloma — an incidentally discovered lesion in an asymptomatic person. The vast majority are benign: simple liver cysts, kidney cysts, small thyroid nodules, benign vertebral hemangiomas, small adrenal adenomas. The minority that warrant follow-up typically fall into a few buckets:

• "Probably benign, follow up in 6 months" — the most common ambiguous category. The radiologist's confidence is high but not 100%, and a single follow-up scan typically resolves the question. Examples: small indeterminate liver lesions, small lung nodules.
• "Recommend specialist consult" — a finding that needs interpretation by an organ-specific specialist (e.g., a 1.2 cm thyroid nodule requires endocrine follow-up with ultrasound and possibly fine-needle aspiration).
• "Recommend prompt diagnostic workup" — rare but possible. Findings concerning for malignancy or significant pathology. In the rare case this happens during a Taiwan trip, our concierge connects you to a relevant specialist within 24 hours; for U.S.-resident patients, we coordinate the records handoff to your home oncologist or surgeon.

The 5-year survival differential is the reason patients accept the small psychological cost of incidentalomas. Stage I pancreatic cancer carries roughly 44% 5-year survival vs. ~3% at Stage IV. Stage I lung cancer: 65% vs. 7% at Stage IV. Stage I ovarian: 93% vs. 31% at Stage IV. The detection asymmetry — finding cancer earlier, even at the cost of occasional false-positive workup — is the trade most patients make consciously.

USPSTF Grade A/B versus what's missing

The Affordable Care Act requires commercial insurance to cover, with no cost-sharing, services rated USPSTF Grade A or B. The list is shorter than most patients realize. Here's the gap that drives Taiwan demand:

This list is not arbitrary. The USPSTF requires randomized controlled trial evidence of benefit at the population level — which is hard to achieve for whole-body screening because of the trial size, duration, and outcome ambiguity required. The absence of a Grade A/B rating doesn't mean the screening is useless; it means the evidence threshold for population-level coverage hasn't been met. Individual patients with elevated risk profiles often benefit anyway, which is precisely the gap our Taiwan packages fill. For a fuller treatment of this dynamic, see Preventive health gaps in the U.S. and how Taiwan fills the void.

Who this isn't for

If you're symptomatic, this isn't the right protocol. Acute chest pain, neurological symptoms, or anything that would normally trigger an emergency-room visit needs to be addressed at home. Screening is by definition for asymptomatic adults seeking a baseline or longitudinal tracking — not a substitute for diagnostic workup.

Similarly, if you have a complex pre-existing condition that requires close coordination with your home physician, the right move is often to stay close to your existing care team. We screen this on the intake call and will say so directly.

Sources & Further Reading

• USPSTF — U.S. Preventive Services Task Force recommendations
• American Cancer Society — Cancer Facts & Figures
• NCI SEER — Surveillance, Epidemiology, and End Results Program
• CDC — Cancer prevention & screening
• American Heart Association — heart attack risk
• American College of Cardiology — clinical guidelines

Frequently asked questions